Skip to content
Screener

Bio-Rad Laboratories BIO Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Abbott logo
AbbottABT
$1.13B+4.7%
Danaher logo
DanaherDHR
$1.2B+9.1%
MaxCyte logo
MaxCyteMXCT
$10.7M-7.3%
Quanterix Corporation logo
Quanterix CorporationQTRX
$15.86M-0.7%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$155.8M-0.8%
Revvity logo
RevvityRVTY
$163.25M-6.0%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.16B+28.0%
Enterprise value$9.63B+17.5%
P/E54.2×+31.8×
P/S3.5×+0.7×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Line itemMarch 31, 2026December 31, 2025
Weighted Average Remaining Lease Term
Operating leases - in years77
Finance leases - in years1213
Weighted Average Discount Rate
Operating leases4.8%4.8%
Finance leases6.7%6.7%

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's operating lease ROU assets?
Bio-Rad Laboratories (BIO) reported operating lease ROU assets of 4.8% in Q1 2026.
How has Bio-Rad Laboratories's operating lease ROU assets changed year-over-year?
Bio-Rad Laboratories's operating lease ROU assets increased by 17.1% year-over-year, from 4.1% to 4.8%.
What is the long-term trend for Bio-Rad Laboratories's operating lease ROU assets?
Over 5 years (2020 to 2025), Bio-Rad Laboratories's operating lease ROU assets has grown at a -98.8% compound annual growth rate (CAGR), from 20,213,600,000% to 4.8%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Bio-Rad Laboratories's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude